PANTHERx® Rare Pharmacy Named to the Fortune Change the World 2026 List

One of 50 organizations honored worldwide, PANTHERx was recognized for its commitment to supporting people living with rare diseases throughout their treatment journey

PITTSBURGH, Oct. 27, 2026 /PRNewswire/ -- PANTHERx® Rare, the nation's leading independent rare pharmacy, was named to the Fortune Change the World 2026 List, which recognizes companies that are having positive social impact through activities that are part of their core business strategy. PANTHERx was one of just 50 organizations worldwide selected this year and was included in the "Serving the Underserved" category.

Fortune cited PANTHERx for helping people living with rare diseases overcome the clinical, financial, and administrative barriers that can stand between a prescription and successful treatment. For many rare disease patients and their families, the path to care is marked by uncertainty, delayed diagnoses, complex insurance requirements, and limited access to specialized support. PANTHERx designed and continues to evolve its model to help patients overcome these obstacles and benefit from life-changing therapies.

"Living with a rare disease can feel overwhelming, not only because of the condition itself, but because of the many challenges patients and families face in accessing and staying on treatment," said Bansi Nagji, Chief Executive Officer of PANTHERx Rare. "Every day, our teams work alongside patients at some of their most vulnerable moments. Being named to the Fortune Change the World 2026 List reflects our people's unwavering commitment to improving the lives of rare disease patients."

More than 30 million Americans live with a rare disease, yet most rare diseases still lack an FDA-approved treatment. As new therapies emerge, ensuring patients can start and stay on therapy continues to be a critical challenge. Through its RxARECARE® operating system, PANTHERx helps patients navigate that journey with highly personalized support, expert care, and relentless advocacy.

About PANTHERx Rare Pharmacy
PANTHERx Rare makes rare disease care more hyper-personalized and less overwhelming by focusing relentlessly on each patient and each therapy. PANTHERx experts develop deep personal relationships with patients, prescribers, and pharmaceutical partners, serving as trusted advocates to ensure seamless collaboration and exceptional care. Since its founding in a garage in Pittsburgh, PA in 2011, PANTHERx has grown into the largest independent rare pharmacy in the U.S., leveraging established-company resources while maintaining small-company responsiveness, innovation, and attention to detail.

PANTHERx is licensed in all 50 states and was the first national pharmacy to achieve dual accreditations in rare disease from the Accreditation Commission for Health Care (ACHC) and Utilization Review Accreditation Commission (URAC). PANTHERx is also the nine-time winner of the prestigious MMIT Patient Choice Award for patient satisfaction, including the 2026 honor.

For more information, please email [email protected] or visit www.pantherxrare.com. 

Media Contact:
Jennifer May
Senior Manager, Marketing Communications
[email protected]

SOURCE PANTHERx Rare Pharmacy